HER3 is a determinant for poor prognosis in melanoma.
Reschke M, Mihic-Probst D, van der Horst EH, Knyazev P, Wild PJ, Hutterer M, Meyer S, Dummer R, Moch H, Ullrich A.
Reschke M, et al.
Clin Cancer Res. 2008 Aug 15;14(16):5188-97. doi: 10.1158/1078-0432.CCR-08-0186.
Clin Cancer Res. 2008.
PMID: 18698037
Free article.